CN Patent

CN1642546A — 含有单一晶型的固体制剂

Assigned to Teijin Pharma Ltd · Expires 2005-07-20 · 21y expired

What this patent protects

提供含有2－(3－氰基－4－异丁氧基苯基)－4－甲基－5－噻唑羧酸的单一结晶、赋形剂及崩解剂的固体制剂及其制造方法。

USPTO Abstract

提供含有2－(3－氰基－4－异丁氧基苯基)－4－甲基－5－噻唑羧酸的单一结晶、赋形剂及崩解剂的固体制剂及其制造方法。

Drugs covered by this patent

Uloric (FEBUXOSTAT) · Takeda

Patent Metadata

Patent number: CN1642546A
Jurisdiction: CN
Classification: —
Expires: 2005-07-20
Drug substance claim: No
Drug product claim: No
Assignee: Teijin Pharma Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.